Nifty 50
- Tech Mahindra₹1,65074.80 (4.75%)
- Nestle₹1,275.80-107.40 (-7.76%)
- ICICI Bank₹1,389.4050.80 (3.80%)
- Adani Enterprises₹2,700-22.60 (-0.83%)
- Reliance Industries₹1,21540.40 (3.44%)
- Trent₹2,949.70-21.30 (-0.72%)
- Bharti Airtel₹1,85459.40 (3.31%)
- Shriram Finance₹943.80-6.20 (-0.65%)
- BSE₹3,42890.00 (2.70%)
- Bharat Electronics₹380.40-1.95 (-0.51%)
- HCL Technologies₹1,36033.00 (2.49%)
- ONGC₹224.64-0.86 (-0.38%)
- Mahindra & Mahindra₹2,861.7068.00 (2.43%)
- Adani Ports₹1,743.20-5.50 (-0.31%)
- Maruti Suzuki₹11,445267.00 (2.39%)
- L&T₹3,632-10.00 (-0.27%)
- HDFC Bank₹726.8516.15 (2.27%)
- Kotak Mahindra Bank₹447.959.90 (2.26%)
- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Margin Pledge Calculator
- Algo Strategy
- Markets
Stocks
F&O
Mutual Funds
- More
Open Free Demat Account
Open Free Demat Account
Procter & Gamble Health Share Price Today
As of 15-10-2026 18:48, Procter & Gamble Health Ltd. share price today is ₹0, with a change of ₹-5232.50 (-100.00%) from the previous close of ₹5232.5. The stock opened at ₹5258.5 and traded between ₹5122.5 and ₹5259, with a total traded volume of 8366 shares. The company has a market capitalization of ₹8685.6 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹6975 and ₹4707, respectively.
Procter & Gamble Health Ltd. valuation metrics include a P/E ratio of 24.3, and book value of ₹14.00. Profitability indicators show ROE of 62.32% along with a dividend yield of 3.9%. Procter & Gamble Health Ltd. has reported revenue of ₹1432.94 Cr and net profit of ₹356.88 Cr.
Procter & Gamble Health Ltd. technical indicators include Day RSI at 38.05, Day MFI at 60.83, Day ADX at 26.09. Additional indicators include Commodity Channel Index (CCI) at -69.1 and Williams %R at -84.6. Momentum indicators show Day MACD at -125.15, Day MACD Signal Line at -127.07, DayATR at 151.66. Rate of Change indicators for Procter & Gamble Health Ltd. include ROC125 at 5.94 and ROC21 at -3.31.
Exponential moving averages include EMA5 at ₹5247.1, EMA10 at ₹5286.6, EMA12 at ₹5303.9, EMA20 at ₹5374.2, EMA26 at ₹5429, EMA50 at ₹5610, EMA100 at ₹5728.6, EMA200 at ₹5723. Simple moving averages include SMA5 at ₹5218.2, SMA10 at ₹5285.4, SMA20 at ₹5379.2, SMA30 at ₹5447.9, SMA50 at ₹5643, SMA100 at ₹6011.7, SMA150 at ₹5686.9, SMA200 at ₹5602.7.
Support levels for Procter & Gamble Health are placed at First Support ₹5164.00, Second Support ₹5095.50, Third Support ₹4985.50. Resistance levels are seen at First Resistance ₹5342.50, Second Resistance ₹5452.50, Third Resistance ₹5521.00. Procter & Gamble Health Ltd. shareholding pattern shows promoter holding at 51.82%, FII holding at 6.33%, DII holding at 0%, public holding at 29.41%.
Procter & Gamble Health Performance
Price Movement
₹5122.50
₹5259.00
1 Year Performance
₹4707.00
₹6975.00
Markets Today
Historical Performance
Procter & Gamble Health Fundamentals
Procter & Gamble Health Financials
Indicator | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Total Revenue | 363.71 | 370.45 | 373.86 | 324.92 | 338.74 |
| Operating Expense | 264.11 | 234.86 | 263.40 | 204.65 | 248.40 |
| Operating Profit | 99.60 | 135.59 | 110.46 | 120.27 | 90.34 |
| Depreciation | 0.14 | 6.17 | 5.90 | 6.08 | 5.44 |
| Interest | 6.02 | 0.21 | 0.10 | 0.12 | 0.12 |
| Tax | 32.97 | 38.61 | 31.23 | 30.48 | 22.63 |
| Net Profit | 96.15 | 94.60 | 77.59 | 88.54 | 66.18 |
Procter & Gamble Health Technicals
Procter & Gamble Health Ltd. EMA & SMA
₹5130.00
↗ Bullish Moving Average
1
↘ Bearish Moving Average
15
Procter & Gamble Health Support and Resistance
Resistance
Support
Technical Indicators
Procter & Gamble Health Shareholding Pattern
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 51.8 | 51.8 | 51.8 | 51.8 | 51.8 | 51.8 |
| FII | 6.9 | 7 | 7.2 | 7 | 6.2 | 6.3 |
| DII | 14.2 | 14.1 | 13.9 | 13.8 | 13.7 | 12.5 |
| Public | 27.1 | 27 | 27 | 27.4 | 28.3 | 29.4 |
Procter & Gamble Health Delivery And Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 9.34 K | 14.35 K | 65.08% |
| Week | 4.91 K | 8.44 K | 58.16% |
| 1 Month | 6.53 K | 13.48 K | 48.45% |
| 6 Month | 11.78 K | 22.42 K | 52.56% |
Procter & Gamble Health SWOT Analysis
MACD Crossover Above Signal Line
Companies with no Debt
Benjamin Graham Value Screen
Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
Newly Affordable Stocks with Good Financials and Durability (subscription)
Mid-range Performer (DVM)
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Companies with high TTM EPS Growth
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Increasing profits every quarter for the past 2 quarters
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Annual Net Profits improving for last 2 years
Companies with Zero Promoter Pledge
MACD crossed above signal line previous end of day
Volume Shockers
Procter & Gamble Health Corporate Action
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 27 Aug, 2026 | 45 | FINAL | 27 Aug, 2026 | Equity Share |
| 12 Feb, 2026 | 50 | SPECIAL | 12 Feb, 2026 | Equity Share |
| 12 Feb, 2026 | 110 | INTERIM | 12 Feb, 2026 | Equity Share |
| 22 Aug, 2025 | 45 | FINAL | 22 Aug, 2025 | Equity Share |
| 21 Feb, 2025 | 80 | INTERIM | 21 Feb, 2025 | Equity Share |
| 28 Nov, 2024 | 60 | FINAL | Equity Share | |
| 14 Feb, 2024 | 50 | INTERIM | 14 Feb, 2024 | Equity Share |
| 14 Feb, 2024 | 150 | SPECIAL | 14 Feb, 2024 | Equity Share |
| 23 Nov, 2023 | 50 | FINAL | Equity Share | |
| 13 Feb, 2023 | 45 | INTERIM | 13 Feb, 2023 | Equity Share |
Procter & Gamble Health Stock Comparison
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,245 | ₹2,042 | ₹1,012 | ₹1,257.10 | ₹1,433 | ₹3,562 |
| % Change | -0.65% | -0.85% | -4.09% | -1.90% | -0.65% | -1.44% |
| Revenue TTM (₹ Cr) | - | ₹1,479.07 | ₹675.61 | ₹691.72 | ₹1,543.34 | ₹949.80 |
| Net Profit TTM (₹ Cr) | - | ₹199.03 | ₹182.64 | ₹126.37 | ₹-48.62 | ₹266 |
| PE TTM | - | 63.30 | 65.30 | 46.70 | -340.20 | 31.30 |
| 1 Year Return | 26.84 | 93.94 | 77.94 | 79.32 | -21.57 | -23.07 |
| ROCE | 14.97 | 31.54 | 24.22 | 15.60 | 0.59 | - |
Similar Stocks
AKUMS
Akums Drugs & Pharmaceuticals Ltd.
₹ 746.00
-3.11%
INNOVACAP
Innova Captab Ltd.
₹ 1016.00
-3.55%
BLUEJET
Blue Jet Healthcare Ltd
₹ 518.10
-0.83%
CONCORDBIO
Concord Biotech Ltd.
₹ 1354.80
-1.98%
AARTIPHARM
Aarti Pharmalabs Ltd.
₹ 867.00
-0.07%
SUPRIYA
Supriya Lifescience Ltd.
₹ 872.50
-0.23%
ALIVUS
Alivus Life Sciences Ltd.
₹ 1340.00
-0.59%
COHANCE
Cohance Lifesciences Ltd.
₹ 460.45
+3.33%
ERIS
Eris Lifesciences Ltd.
₹ 1145.10
-0.39%
SYNGENE
Syngene International Ltd.
₹ 385.00
-1.41%
APLLTD
Alembic Pharmaceuticals Ltd.
₹ 790.60
-0.23%
SPARC
Sun Pharma Advanced Research Company Ltd.
₹ 188.00
-1.99%
STAR
Strides Pharma Science Ltd.
₹ 1062.00
-2.10%
FDC
FDC Ltd.
₹ 353.80
+1.51%
SHILPAMED
Shilpa Medicare Ltd.
₹ 925.00
-3.86%
JUBLPHARMA
Jubilant Pharmova Ltd.
₹ 940.80
+0.20%
NATCOPHARM
Natco Pharma Ltd.
₹ 785.20
+0.33%
CAPLIPOINT
Caplin Point Laboratories Ltd.
₹ 2301.70
-1.56%
MARKSANS
Marksans Pharma Ltd.
₹ 307.55
-2.10%
ORCHPHARMA
Orchid Pharma Ltd.
₹ 925.00
-2.14%
IOLCP
IOL Chemicals and Pharmaceuticals Ltd.
₹ 194.94
-4.30%
VIYASH
Viyash Scientific Ltd.
₹ 224.52
-3.63%
GUJTHEM
Gujarat Themis Biosyn Ltd.
₹ 367.00
-5.69%
ASTRAZEN
AstraZeneca Pharma India Ltd.
₹ 5978.00
+0.46%
BLISSGVS
Bliss GVS Pharma Ltd.
₹ 652.00
-1.32%
FAQ's on PGHL
What is the current share price of Procter & Gamble Health Ltd.?
What is the Market Capitalization of Procter & Gamble Health Ltd.?
What are the PE and PB ratios for Procter & Gamble Health Ltd.?
What is the 52-Week High and Low for Procter & Gamble Health Ltd.?
What is the current dividend yield for Procter & Gamble Health Ltd.?
Who are the major shareholders of Procter & Gamble Health Ltd.?
Who are the peers of Procter & Gamble Health Ltd. in the Pharmaceuticals & Biotechnology sector?
What is the latest dividend information for Procter & Gamble Health Ltd.?
By signing up I certify terms, conditions & privacy policy

